Contact
Please use this form to send email to PR contact of this press release:
ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein Vaccine
TO:
Please use this form to send email to PR contact of this press release:
ProMIS Neurosciences Achieves Milestone in Development of Therapeutic Alpha-Synuclein Vaccine
TO: